Ebixa dosing made easier
Ebixa (memantine) is now licensed for once-daily administration in the treatment of patients with moderate to severe Alzheimer's disease.
This site is intended for UK healthcare professionals
Ebixa (memantine) is now licensed for once-daily administration in the treatment of patients with moderate to severe Alzheimer's disease.
The most up-to-date drug information at your fingertips.
A neuromuscular training device for patients with reflux-based...
EXCLUSIVE TO SUBSCRIBERS See the latest products removed...
EXCLUSIVE TO SUBSCRIBERS See the latest changes to...
Use our constantly updated shortages tracker to check...